MOA Life Plus Co., Ltd. engages in the development of biopharmaceutical products. The company operates through the following business divisions: Bio-New Treatment and Product. Its products include poly-y-glutamic acid, lactobacillus plantarum BLS41, and skincare products. The company was founded on December 30, 1999 and is headquartered in Yongin-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company